Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $32,534 | 704 | 99.8% |
| Consulting Fee | $53.91 | 3 | 0.2% |
| Education | $14.56 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ERBE USA Inc | $17,812 | 1 | $0 (2019) |
| ABBVIE INC. | $5,533 | 241 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,387 | 70 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $959.85 | 73 | $0 (2024) |
| Janssen Biotech, Inc. | $916.95 | 37 | $0 (2024) |
| Celgene Corporation | $557.59 | 44 | $0 (2024) |
| GENZYME CORPORATION | $514.71 | 24 | $0 (2024) |
| PFIZER INC. | $479.75 | 20 | $0 (2024) |
| Allergan, Inc. | $428.63 | 24 | $0 (2020) |
| Gilead Sciences, Inc. | $406.22 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,337 | 150 | ABBVIE INC. ($1,412) |
| 2023 | $2,936 | 145 | AbbVie Inc. ($1,420) |
| 2022 | $2,326 | 107 | ABBVIE INC. ($847.66) |
| 2021 | $141.82 | 2 | AbbVie Inc. ($124.99) |
| 2020 | $259.46 | 16 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($73.41) |
| 2019 | $19,148 | 72 | ERBE USA Inc ($17,812) |
| 2018 | $2,454 | 118 | AbbVie, Inc. ($671.71) |
| 2017 | $1,999 | 98 | AbbVie, Inc. ($613.89) |
All Payment Transactions
708 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Immunology | ||||||
| 12/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: Immunology | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Immunology | ||||||
| 12/06/2024 | ALBIREO PHARMA, INC. | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Rare Disease | ||||||
| 12/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $48.20 | General |
| Category: LIVER DISEASE | ||||||
| 11/22/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Immunology | ||||||
| 11/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ALBIREO PHARMA, INC. | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Rare Disease | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/31/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.47 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 966 | 1,008 | $710,003 | $103,388 |
| 2022 | 14 | 974 | 1,009 | $773,728 | $110,466 |
| 2021 | 16 | 964 | 1,001 | $461,523 | $101,072 |
| 2020 | 13 | 1,105 | 1,171 | $463,347 | $100,402 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 104 | 104 | $134,888 | $21,789 | 16.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 159 | 159 | $200,340 | $14,922 | 7.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 64 | 64 | $62,080 | $12,078 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 127 | 149 | $36,505 | $10,866 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 103 | $35,535 | $10,439 | 29.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 95 | 95 | $28,690 | $7,984 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $27,714 | $7,717 | 27.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 109 | 110 | $122,430 | $7,709 | 6.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 23 | 23 | $22,310 | $4,415 | 19.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 53 | 53 | $10,494 | $2,740 | 26.1% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 17 | 17 | $24,820 | $2,248 | 9.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 31 | $403.00 | $260.40 | 64.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 16 | 20 | $860.00 | $152.20 | 17.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 18 | 18 | $2,934 | $67.65 | 2.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 122 | 123 | $159,531 | $25,892 | 16.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 175 | 176 | $221,760 | $14,325 | 6.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 68 | 68 | $65,960 | $13,610 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 131 | $32,095 | $10,080 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 89 | $30,705 | $9,634 | 31.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $29,055 | $9,194 | 31.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 125 | 126 | $140,238 | $8,562 | 6.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 94 | 94 | $28,388 | $8,505 | 30.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 18 | 18 | $17,460 | $3,612 | 20.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $15,520 | $2,478 | 16.0% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2022 | 16 | 16 | $23,360 | $2,273 | 9.7% |
About Dr. Edward Block, M.D
Dr. Edward Block, M.D is a Specialist healthcare provider based in Mission Viejo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811973860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Block, M.D has received a total of $32,602 in payments from pharmaceutical and medical device companies, with $3,337 received in 2024. These payments were reported across 708 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($32,534).
As a Medicare-enrolled provider, Block has provided services to 4,009 Medicare beneficiaries, totaling 4,189 services with total Medicare billing of $415,328. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Gastroenterology
- Location Mission Viejo, CA
- Active Since 12/21/2005
- Last Updated 01/22/2013
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1811973860
Products in Payments
- ERBE (Device) $17,812
- RINVOQ (Biological) $1,979
- SKYRIZI (Biological) $1,414
- XIFAXAN (Drug) $1,188
- Humira (Biological) $1,071
- ZEPOSIA (Drug) $776.58
- DUPIXENT (Biological) $642.07
- ENTYVIO (Biological) $624.92
- STELARA (Biological) $599.97
- XELJANZ (Drug) $448.53
- LINZESS (Drug) $406.87
- ZENPEP (Drug) $307.97
- UCERIS (Drug) $266.35
- TREMFYA (Drug) $265.49
- Creon (Drug) $251.56
- Trulance (Drug) $240.87
- Epclusa (Drug) $226.32
- OCALIVA (Drug) $186.65
- CREON (Drug) $181.26
- INJECTAFER (Drug) $165.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Mission Viejo
Dr. Luis Chanes, M.d, M.D
Specialist — Payments: $4,742
Dr. Viken Melkonian, M.d, M.D
Specialist — Payments: $4,318
Patricia Wallace, Md, MD
Specialist — Payments: $3,061
Dr. Christopher Thompson, M.d, M.D
Specialist — Payments: $2,428
Dr. Kym Kanaly, M.d, M.D
Specialist — Payments: $2,088
Dr. Michael Jakobsen, Md, MD
Specialist — Payments: $1,278